AGC Biologics and Evax Partner to Advance Promising Equine Allergy Vaccine Candidate
September 07, 2022 17:00 ET
|
AGC Biologics
Seattle, Sept. 07, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with Evax,...
Insecticides Market Size is projected to reach USD 22 Billion by 2030, growing at a CAGR of 5%: Straits Research
July 13, 2022 13:10 ET
|
Straits Research
New York, United States, July 13, 2022 (GLOBE NEWSWIRE) -- All active chemicals employed to manage insect pests, particularly biological insecticides and Microbial insecticides, were studied as part...
AGC Biologics Named Manufacturing Company of the year by American Business Awards
June 29, 2022 09:09 ET
|
AGC Biologics
SEATTLE, June 29, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it was named Company of the...
AGC Biologics Honored as a Top 10 Company for Pharma Quality Assurance
June 09, 2022 08:22 ET
|
AGC Biologics
SEATTLE, June 09, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has been named a Top 10...
Kane Biotech Announces Update on Private Placement
May 06, 2022 08:30 ET
|
Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 06, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane...
Kane Biotech Announces Extension of Private Placement Offering
April 29, 2022 16:05 ET
|
Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, April 29, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane...
Single-Cell Analysis Market Size Worth USD 6.98 Bn By 2027 | CAGR:17.2% | Reports and Data
December 14, 2020 09:22 ET
|
Reports and Data
New York, Dec. 14, 2020 (GLOBE NEWSWIRE) -- The increasing emphasis on personalized medicine and the government's growing investment in cell-based research are driving the demand for the market. ...
Kane Biotech Appoints New Advisor
September 23, 2020 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Company,” “Kane Biotech”) today announced that it has entered into an agreement with Harbor Access...
Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing
March 03, 2020 08:00 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif. and HINXTON, United Kingdom, March 03, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an industry leader in microfluidics technology, and Next Gen...
Biopesticides Market worth over $2.5bn by 2024: Global Market Insights, Inc.
May 24, 2017 05:30 ET
|
Global Market Insights, Inc
Ocean View, Delaware, May 24, 2017 (GLOBE NEWSWIRE) -- The industry growth report “Biopesticides Market Size By Product (Bioherbicides, Bioinsecticides, Biofungicides), By Application (Seed...